IDEXX Laboratoriesvs.Natera
IDXX vs NTRA · both in Diagnostics, part of the Medicine, pharma & life science value chain: Tests, imaging and assays that support clinical decision-making.
IDEXX Laboratories and Natera are similar in size by market cap; year to date, Natera leads (+43.1% vs −17.3%).
Side by side
| IDXX | NTRA | |
|---|---|---|
| Market cap | $44.4B | $44.6B |
| Price | $550.01 | $336.71 |
| Today | −1.7% | +2.7% |
| Return YTD | −17.3% | +43.1% |
| Return 1Y | −13.3% | +97.9% |
| P/E | 39.0 | — |
| P/S | 9.8 | 16.5 |
| P/B | 27.6 | 24.5 |
Data as of 2026-08-26 · updates daily after U.S. close
The two companies
IDEXX LaboratoriesIDXX
Vets are the customers. IDEXX sells the analysers that sit in the clinic, runs the reference laboratories that handle samples sent out, and writes the software the practice runs on.
Full IDXX profile →NateraNTRA
Genetic testing put to three uses: Panorama screens pregnancies, Signatera works in oncology, and a third line covers transplant medicine.
Full NTRA profile →More IDXX & NTRA comparisons
Other head-to-heads in the Diagnostics segment.
See where IDXX and NTRA sit in the full Medicine, pharma & life science map: every segment from suppliers to end markets.Open the Life science value chain →